Clinical Trial Update: STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating STI571 (imatinib) in combination with chemotherapy for chronic myelogeno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphocytic Leukemia
• Myelogenous Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED